CARDIO-THORACIC & VASCULAR CLINIC

CARDIO-THORACIC & VASCULAR CLINICCARDIO-THORACIC & VASCULAR CLINICCARDIO-THORACIC & VASCULAR CLINIC
  • Home
  • CARDIAC
    • AORTIC VALVE
    • ASD
    • CAD - HEART ATTACK
    • CORONARY ANGIOGRAPHY
    • PCI (STENTING)
    • CABG
    • CABG OR STENTING
    • DVR
    • MITRAL VALVE
    • MICS-KEY HOLE SURGERY
    • PDA
    • PULMONARY ENDARTERECTOMY
    • RSOV
    • VSD
    • VIT-K AND YOUR DIET
  • VASCULAR
    • AORTIC ANEURYSM
    • AORTIC DISSECTION
    • AV FISTULA
    • CAROTID ARTERY DISEASE
    • Embolectomy
    • PERIPHERAL ARTERY DISEASE
  • THORACIC
    • DECORTICATION
    • CHEST DEFORMITY
    • CHEST TRAUMA
    • LOBECTOMY
    • PNEUMONECTOMY
    • PARTIAL LUNG RESECTION
    • MISCLLANEOUS
  • VEIN CLINIC
    • VARICOSE VEINS
    • DVT
    • GLUE VARICOSE ABLATION
    • RF VARICOSE ABLATION
  • ONLINE APPOINTMENT
  • About Us
  • Contact Us
  • DISCLAIMER
  • More
    • Home
    • CARDIAC
      • AORTIC VALVE
      • ASD
      • CAD - HEART ATTACK
      • CORONARY ANGIOGRAPHY
      • PCI (STENTING)
      • CABG
      • CABG OR STENTING
      • DVR
      • MITRAL VALVE
      • MICS-KEY HOLE SURGERY
      • PDA
      • PULMONARY ENDARTERECTOMY
      • RSOV
      • VSD
      • VIT-K AND YOUR DIET
    • VASCULAR
      • AORTIC ANEURYSM
      • AORTIC DISSECTION
      • AV FISTULA
      • CAROTID ARTERY DISEASE
      • Embolectomy
      • PERIPHERAL ARTERY DISEASE
    • THORACIC
      • DECORTICATION
      • CHEST DEFORMITY
      • CHEST TRAUMA
      • LOBECTOMY
      • PNEUMONECTOMY
      • PARTIAL LUNG RESECTION
      • MISCLLANEOUS
    • VEIN CLINIC
      • VARICOSE VEINS
      • DVT
      • GLUE VARICOSE ABLATION
      • RF VARICOSE ABLATION
    • ONLINE APPOINTMENT
    • About Us
    • Contact Us
    • DISCLAIMER

CARDIO-THORACIC & VASCULAR CLINIC

CARDIO-THORACIC & VASCULAR CLINICCARDIO-THORACIC & VASCULAR CLINICCARDIO-THORACIC & VASCULAR CLINIC
  • Home
  • CARDIAC
    • AORTIC VALVE
    • ASD
    • CAD - HEART ATTACK
    • CORONARY ANGIOGRAPHY
    • PCI (STENTING)
    • CABG
    • CABG OR STENTING
    • DVR
    • MITRAL VALVE
    • MICS-KEY HOLE SURGERY
    • PDA
    • PULMONARY ENDARTERECTOMY
    • RSOV
    • VSD
    • VIT-K AND YOUR DIET
  • VASCULAR
    • AORTIC ANEURYSM
    • AORTIC DISSECTION
    • AV FISTULA
    • CAROTID ARTERY DISEASE
    • Embolectomy
    • PERIPHERAL ARTERY DISEASE
  • THORACIC
    • DECORTICATION
    • CHEST DEFORMITY
    • CHEST TRAUMA
    • LOBECTOMY
    • PNEUMONECTOMY
    • PARTIAL LUNG RESECTION
    • MISCLLANEOUS
  • VEIN CLINIC
    • VARICOSE VEINS
    • DVT
    • GLUE VARICOSE ABLATION
    • RF VARICOSE ABLATION
  • ONLINE APPOINTMENT
  • About Us
  • Contact Us
  • DISCLAIMER

CABG vs PCI (STENTING) DIFFERENCE IN MEHCANISM

CABG

PCI (STENTING)

PCI (STENTING)

In Bypass Graft Surgery there is no metallic or foreign body is used inside the blocked artery. In CABG natural available grafts (artery or vein) is used to place it on healthy part of the blocked artery and does not disturb the disease in the artery.  Bypass of a coronary artery improves blood flow

to the jeopardized heart muscle supplied by the diseased

artery and also protect the distal heart muscles beds from future ischemic insult (heart attack) caused by proximal disease progression, plaque  progression or rupture .

PCI (STENTING)

PCI (STENTING)

PCI (STENTING)

PCI (STENTING) procedure involves opening of the coronary artery by directly relieving a localized  obstruction and placing a metallic stent coated with drugs to maintain the patency of the arterial lumen. This increases the arterial lumen in the stented area but have no effect on preventing disease progression, plaque progression or rupture in other diseased segments within the artery.

cabg or pci (stenting)

HEART TEAM APPROACH

Heart team  includes cardiologist and a cardiac surgeon as team members . Heart team approach that means both the  members of the heart team are available at the time of your decision making of the treatment of your coronary artery revascularization without any pressure on the patient. This is more important when the decision of the best modality for coronary revascularization is unclear, when patient has multiple coronary artery blocks or left main artery disease , also has other structural heart disease with coronary blocks.

These members should focus on the best possible treatment modality for the patient for the best possible clinical outcome.

Without heart team approach decision can be biased without proper explanation of the each modality available for the treatment and it's advantages and disadvantages to the patient and his family for proper decision.


Some important factors for special consideration by heart team  are as follows-

  1. Left main artery disease
  2. Multiple vessel disease / Triple Vessels Disease (TVD)
  3. Complicated anatomy of the diseased arteries.
  4. Calcification of the arteries
  5. Aortic calcification
  6. Valvular heart disease
  7. Diabetes
  8. Coagulopathy
  9. Kidney disease
  10. Stenting risk
  11. Surgery risk
  12. Condition of the patient (Unstable)
  13. Patient preferences
  14. Inability to take dual antiplatelet therapy 
  15. Education, knowledge  of the patient
  16. Religious beliefs 

HEART TEAM

classification of coronary artery diseases

STEMI

NSTEMI

NSTEMI

Acute Coronary Syndrome (ACS) is group of symptoms associated with acute coronary artery ischemia. ACS is defined as STEMI (ST- elevation myocardial infarct) when ECG findings with ST segment elevation is evident. It occurs due to the complete and prolonged occlusion of an epicardial coronary artery.

NSTEMI

NSTEMI

NSTEMI

ACS in which there is no ECG findings of ST  segment elevation is defined as NSTEMI (Non-ST elevation MI). It is due to  severe coronary artery narrowing, transient occlusion, or microembolization of thrombus and/or atheromatous plaque material.

SIHD

NSTEMI

LEFT MAIN DISEASE

 Stable ischemic heart disease (SIHD)  is the condition in which there is mismatch between demand and supply of the blood to the heart muscle. It is due to the chronic occlusion of the heart arteries but there is no sign and symptoms of the acute heart muscle damage as in STEMI.

LEFT MAIN DISEASE

SVD (LAD OR NON LAD)

LEFT MAIN DISEASE

Left main artery divides in two ( LAD and LCX) or sometimes three (LAD,LCX and RI). The disease involving in the main segment of this artery is left main disease.

SVD (LAD OR NON LAD)

SVD (LAD OR NON LAD)

SVD (LAD OR NON LAD)

Coronary artery disease involving only one vessel. This could involve only LAD or other artery.

MULTI VESSELS OR TVD

SVD (LAD OR NON LAD)

SVD (LAD OR NON LAD)

Disease involving more than one vessels. When the disease involve all the three arteries , its is known as TVD( Triple- Vessel Disease) .

cabg or stenting (pci)

CABG VS PCI

CABG VS PCI

CABG VS PCI

 At each milestone in percutaneous technology, PCI has been tested against the “gold standard” of CABG with respect to effects on mortality and quality of life. Randomized trials have shown superiority of CABG over PCI in patients with higher disease burden and lesion complexity1 and in the presence of diabetes.2 


 However, for the relatively healthy patients with multivessel coronary disease represented in this trial, we should conclude that CABG is the preferred approach, with the understanding that there are increased short-term risks inherent with CABG. A putative advantage of CABG in this context is that the use of surgical grafts bypasses not only the flow-limiting lesion but also a substantial length of coronary vessel, and subsequent atherothrombotic events along that length are rendered less impactful. 

REFERENCES

CABG VS PCI

CABG VS PCI

 January 13, 2022
N Engl J Med 2022; 386:185-187
DOI: 10.1056/NEJMe2117325 


 1.Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-972. 


 2.Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012;367:2375-2384. 

SOME impoRtant recommendation IN STEMI

STEMI- REVASCULARISATION OF THE CULPRIT ARTERY

STEMI- REVASCULARISATION OF NONCULPRIT ARTERIES (NOT 100% OCCLUDED)

STEMI- REVASCULARISATION OF NONCULPRIT ARTERIES (NOT 100% OCCLUDED)

 In patients with acute heart attack STEMI and symptoms

for <12 hours, PCI (Stenting) should be performed

to improve survival. 


But if the patient has cardiogenic shock or hemodynamic instability, PCI or CABG(when PCI(stenting) is not feasible) is indicated to improve survival, irrespective of the time delay

from MI onset.


The patients who have mechanical complications (like VSR, Severe MR due to papillary muscle infarction or rupture, or free wall rupture), CABG is recommended.


In asymptomatic stable patients who have a totally occluded infarct artery >24 hours after symptom onset and are without evidence of severe ischemia, PCI(stenting) should not be performed.


In patients with STEMI, emergency CABG should

not be performed after failed primary PCI:

 In the absence of ischemia or a large area of

myocardium at risk, or

 If surgical revascularization is not feasible because

of a no-reflow state or poor distal targets.

STEMI- REVASCULARISATION OF NONCULPRIT ARTERIES (NOT 100% OCCLUDED)

STEMI- REVASCULARISATION OF NONCULPRIT ARTERIES (NOT 100% OCCLUDED)

STEMI- REVASCULARISATION OF NONCULPRIT ARTERIES (NOT 100% OCCLUDED)

 In selected hemodynamically stable patients with acute heart attack STEMI and multivessel disease, after

successful primary PCI, staged PCI of a significant

non-infarct artery stenosis is recommended

to reduce further risk of death or heart attack.


 In some patients with STEMI with complex multivessel non-culprit  artery disease, after successful primary PCI, elective CABG is reasonable to reduce the risk of heart attack or other heart problem related to ischemia.


In some stable patients with STEMI and low-complexity multivessel disease, PCI of a non-culprit artery stenosis

may be considered at the time of primary PCI to reduce cardiac event rates.


In patients with acute heart attack STEMI complicated by cardiogenic shock, routine PCI of a non-culprit vessel  at the time of primary PCI should not be performed because of the higher risk of death or kidney failure.

IMPORTANT RECOMMENDATION IN SIHD

Left ventricular dysfunction and multivessel CAD

Left ventricular dysfunction and multivessel CAD

Left ventricular dysfunction and multivessel CAD

The patients with SIHD and multivessel CAD (TVD) with severe LV dysfunction (LVEF < 35%) fit for surgery,  for them CABG is recommended to improve survival.


In some patients with SIHD and multivessel

CAD (or TVD) with mild to moderate LV dysfunction (LVEF 35% to 50%) fit for surgery CABG (with internal mammary arterial graft to the LAD(LIMA-LAD)) is reasonable to improve survival.


There is no study till date which proves survival benefits of PCI (Stenting) in theses cases. Survival benefits are uncertain with PCI (Stenting)

Left main CAD

Left ventricular dysfunction and multivessel CAD

Left ventricular dysfunction and multivessel CAD

In patients with SIHD who have significant left main disease, CABG is recommended to improve survival. (Class I recommendation).


In some patients with SIHD (low complex disease) and significant left main disease for whom PCI(Stenting) can provide equivalent revascularization to that possible with CABG,PCI(Stenting) is reasonable to improve survival.(Class 2a Recommendation).


The Syntax Score should be used to define the complexity of the multiple vessel disease.



Multivessel CAD without lv dysfunction

Multivessel CAD without lv dysfunction

Multivessel CAD without lv dysfunction

In patients with SIHD, normal LV significant stenosis in 3 major coronary arteries (with or without proximal LAD), and

anatomy suitable for CABG, CABG may be reasonable to improve survival.


In patients with SIHD, normal LV significant stenosis in 3 major coronary arteries (with or without proximal LAD), and

anatomy suitable for PCI, the usefulness of

PCI to improve survival is uncertain.

Stenosis in the proximal LAD artery

Multivessel CAD without lv dysfunction

Multivessel CAD without lv dysfunction

 In patients with SIHD, normal LVEF, and significant stenosis in the proximal LAD, the usefulness of coronary

revascularization (CABG or PCI) to improve survival is uncertain.

IMPORTANT RECOMMENDATION IN SIHD (continued)

Single- or double-vessel disease not involving the proximal LAD

In patients with SIHD, normal LVEF, and 1- or 2-vessel disease not

involving the proximal LAD, coronary revascularization (CABG or PCI)

is not recommended to improve survival.(No Benefit)


In patients with SIHD who have equal to or more than one coronary

arteries that are not anatomically or functionally significant (<70% diameter of non–left main coronary artery stenosis, FFR >0.80), coronary revascularization should not be performed with the primary or sole intent to improve survival. (Harm)

FOR DETAILED EXPLANATION OF THE CLASS OF RECOMMENDATION FOR CORONARY REVASCULARIZATION AND  FULL TEXT VISIT AHA GUIDELINES.  PRESS THE LINK BELOW.

The American Heart Association is a relentless force for a world of longer, healthier lives for all.

disclaimer

Above recommendations mentioned on this page are derived after studying the current AHA guidelines. All the healthcare , physicians , doctors and surgeons are advised to go through the detailed study of the AHA guidelines available on their official website or through the link given above to direct you to their website.


Copyright © 2022 ctvsuk (Under the aegis of Sushrut Superspeciality Surgical Services Pvt Ltd) - All Rights Reserved.

  • Contact Us

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept